A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus

doi:10.3748/wjg.v17.i38.4321

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 38

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7949)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-2) series.

Item

Count

PDF

553

HTML

6890

Figures (1-7)

257

Tables (1-2)

249

Sum=7949

Oct 14, 2011 (publication date) through Feb 7, 2025

Times Cited of This Article

Times Cited (102)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Oct 14, 2011; 17(38): 4321-4333
Published online Oct 14, 2011. doi: 10.3748/wjg.v17.i38.4321

Full Size Figure Download Figure

Figure 3 Lamivudine treatment vs hepatitis B immunoglobulin in interruption of hepatitis B virus mother-to-child transmission as indicated by newborn serum hepatitis B surface antigen or hepatitis B virus DNA. CI: Confidence interval; HBIG: Hepatitis B immunoglobulin; HBsAg: Hepatitis B surface antigen; HBeAg: Hepatitis B e antigen; HBV: Hepatitis B virus; M-H random: Mantel-Haenszel random-effects model; RR: Risk ratio.

Citation: Han L, Zhang HW, Xie JX, Zhang Q, Wang HY, Cao GW. A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus. World J Gastroenterol 2011; 17(38): 4321-4333
URL: https://www.wjgnet.com/1007-9327/full/v17/i38/4321.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i38.4321